Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J VAN BREEMEN

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 22, 2008
Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalitiesMariëlle J van Breemen, Johannes M F G Aerts, Richard R Sprenger, et al.
Chemistry and Physics of Lipids|August 8, 1997
Slow fusion of liposomes composed of membrane-spanning lipidsM G Elferink, J van Breemen, W N Konings, et al.
Biochimica Et Biophysica Acta|October 3, 2006
Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometryMariëlle J van Breemen, Boris Bleijlevens, Chris G de Koster, et al.
Acta Neuropathologica|January 22, 2003
Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitroRobert Veerhuis, Mariëlle J Van Breemen, Jeroen M Hoozemans, et al.
Analytical Biochemistry|November 3, 2007
Detection of mutant protein in complex biological samples: glucocerebrosidase mutations in Gaucher's diseaseBoris Bleijlevens, Mariëlle J van Breemen, Wilma E Donker-Koopman, et al.
Analytica Chimica Acta|May 22, 2007
Assessing the statistical validity of proteomics based biomarkersSuzanne Smit, Mariëlle J van Breemen, Huub C J Hoefsloot, et al.
Frontiers in Immunology|May 1, 2018
Variable Domain <i>N</i>-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody StabilityFleur S van de Bovenkamp, Ninotska I L Derksen, Mariëlle J van Breemen, et al.
Biochimica Et Biophysica Acta|September 21, 2010
Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapyMariëlle J van Breemen, Saskia M Rombach, Nick Dekker, et al.
Biochimica Et Biophysica Acta|May 15, 2007
Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher diseaseMariëlle J van Breemen, Maaike de Fost, Jane S A Voerman, et al.
Journal of Inherited Metabolic Disease|October 14, 2008
Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type IIIJ Cox-Brinkman, M J van Breemen, B T van Maldegem, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 22, 2008
Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalitiesMariëlle J van Breemen, Johannes M F G Aerts, Richard R Sprenger, et al.
Chemistry and Physics of Lipids|August 8, 1997
Slow fusion of liposomes composed of membrane-spanning lipidsM G Elferink, J van Breemen, W N Konings, et al.
Biochimica Et Biophysica Acta|October 3, 2006
Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometryMariëlle J van Breemen, Boris Bleijlevens, Chris G de Koster, et al.
Acta Neuropathologica|January 22, 2003
Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitroRobert Veerhuis, Mariëlle J Van Breemen, Jeroen M Hoozemans, et al.
Analytical Biochemistry|November 3, 2007
Detection of mutant protein in complex biological samples: glucocerebrosidase mutations in Gaucher's diseaseBoris Bleijlevens, Mariëlle J van Breemen, Wilma E Donker-Koopman, et al.
Analytica Chimica Acta|May 22, 2007
Assessing the statistical validity of proteomics based biomarkersSuzanne Smit, Mariëlle J van Breemen, Huub C J Hoefsloot, et al.
Frontiers in Immunology|May 1, 2018
Variable Domain <i>N</i>-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody StabilityFleur S van de Bovenkamp, Ninotska I L Derksen, Mariëlle J van Breemen, et al.
Biochimica Et Biophysica Acta|September 21, 2010
Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapyMariëlle J van Breemen, Saskia M Rombach, Nick Dekker, et al.
Biochimica Et Biophysica Acta|May 15, 2007
Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher diseaseMariëlle J van Breemen, Maaike de Fost, Jane S A Voerman, et al.
Journal of Inherited Metabolic Disease|October 14, 2008
Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type IIIJ Cox-Brinkman, M J van Breemen, B T van Maldegem, et al.
Pageof 3